Is Belmora LLC Safe? FDA Warning Letter Review (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on July 19, 2017
Executive Summary
The FDA issued a warning letter to Belmora LLC on July 19, 2017 citing regulatory violations. The letter was issued by the FDA.
Detailed Analysis
False Claims and Regulatory Violations
The FDA identified regulatory violations in Belmora LLC's operations or product claims.
Potential Health Risks
Consumers should be aware of potential risks associated with products from Belmora LLC.
Regulatory Context
On July 19, 2017, The Food and Drug Administration completed an evaluation of your firm’s corrective actions in response to our Warning Letter (#521015), dated June 8, 2017. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of the corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
CDR Rochelle B. Young, RPh, MSACompliance Officer
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Belmora LLC?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Belmora LLC products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Belmora LLC products?
- If you have used products from Belmora LLC and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter